Gut Flora and Surgery
Medications such as antibiotics and painkillers – as well as anesthesia and stress – affect the delicate balance in the gut. After surgical procedures, the diversity of microorganisms can remain altered for a longer period.
Typical Consequences of a Disrupted Gut Flora
- slowed recovery
- digestive discomfort
- increased susceptibility to infections
- general weakness
The Solution: Your Own Gut Flora as a Reserve
With Kryobiom®, your gut microbiota is preserved while it is in a stable phase.
After a surgical procedure, it can be made available to you again:
- one-time intake of your Kryobiom® capsules
- restoration of your original microbial diversity
- support of natural regeneration after the operation
What Studies Show
Notable Impact
Surgical procedures, especially in the abdominal area, lead to significant changes in the microbiome.1
Effective Restoration
Autologous reintroduction of microorganisms can support recovery after antibiotic therapy.2
High Efficacy
FMT shows high effectiveness in restoring the gut microbiome and is successfully used in clinical practice.3
Your Benefits with Kryobiom®
- individualized medicinal product made from your own microorganisms
- produced according to pharmaceutical (GMP) standards
- option for reintroduction after surgery
- personal preventive measures in medically stressful situations
Secure your gut flora in advance – for the possibility of future surgery.
Schedule a personal informational appointment.
Further Applications for Kryobiom®
Sports and an Active Lifestyle
Helps stabilize and rebalance the gut microbiome after intense training phases, frequent infections, or the use of medication.
Preventive Use
Preserves your gut microbiome for the coming months — in case it becomes disrupted by illness or medication.
Frequent Infections
Helps restore and rebalance the gut microbiome after antibiotics have disrupted it.
Long-term Preservation
Preservation of your gut microbiome at −130 °C for up to 30 years. Described by Harvard Medical School as the concept of a Microbiome Ark.
1 Ohigashi et al., J Gastrointest Surg, 2013. https://pubmed.ncbi.nlm.nih.gov/23807702/
2 Suez et al., Cell, 2018. https://pubmed.ncbi.nlm.nih.gov/30193113/
3 van Nood et al., N Engl J Med, 2013 (donor-FMT bei C. difficile). https://pubmed.ncbi.nlm.nih.gov/23323867/